3D細胞培養の世界市場：市場規模・シェア・動向分析 (技術別・用途別・最終用途別・地域別・セグメント別、2025年～2030年)

3D細胞培養市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の3D細胞培養市場規模は、2025年から2030年にかけて11.72%のCAGRを記録し、2030年には32億1,000万米ドルに達すると予測されています。

この市場を牽引しているのは、体外検査モデルの技術進歩、個別化医療への注目の高まり、研究開発に対する政府の支援法です。さらに、慢性疾患の有病率の増加と、その治療における細胞治療の重要性の高まりが、業界拡大の勢いを生み出しています。

組織工学は、従来の2D細胞培養よりも生体内培養培地をより正確に模倣した3D培養モデルの作製において大きな発展を遂げました。その結果、毒性試験、創薬、再生医療開発に3D細胞培養システムの利用が増加しました。また、業界各社による最近の製品発表も市場の成長を大きく後押ししています。例えば、2023年6月、Pixelgen Technologies社は、細胞表面に存在するタンパク質の3D空間研究のための初の分子ピクセル化キットを発売しました。

さらに、マイクロ流体工学、バイオプリンティング、ハイコンテントスクリーニングシステムのような先端技術の開発が、これらのモデルの能力を活用しています。これらの技術により、培養条件、細胞組織、高効率スクリーニングの実行能力に対する優れた制御が可能になり、3D培養システムの利用が促進されています。さらに、培養モデルの開発にバイオプリンティングやマイクロ流体技術を活用するための市場関係者間の協力関係の強化が、市場の成長を後押ししています。例えば、AIM BiotechとMatTekは2023年6月に提携し、革新的なidenTXおよびorganiXマイクロ流体3D組織培養プラットフォームを、神経生物学、免疫腫瘍学、血管生物学の特定分野における完全な創薬研究サービスとともに提供しています。

3D培養は、臓器の典型的な微細構造や形態を忠実に再現することができるため、体組織や臓器に対する薬物の効果を分析するためにin vivoモデルを必要とする研究のために継続的に開発されています。この要因は、様々な体外応用のための足場の材料や構造の点でいくつかの選択肢が利用可能であることと相まって、足場の収益を押し上げると予想されます。最近の調査では、グラフェン足場、ナノファイバー、天然海洋コラーゲン、凍結鋳造など、幅広い足場の使用が検討されています。さらに、増殖、刺激、生存率、輸送、高含量スクリーニング、パッチクランピング、代謝活性など、いくつかの種類のアッセイにおけるラボオンチップなどの技術の新たな応用は、高度で効率的なソリューションに対する需要の増加につながると予想されます。

しかし、3D細胞モデル製品の一貫性の欠如は、市場の成長を妨げると予想される主要な欠点の一つです。さらに、細胞培養のばらつき、標準化の課題、スケールと製造の問題、品質管理の問題など、さまざまな要因が市場成長の妨げになる可能性があります。

3D細胞培養市場：分析概要

• スキャフォールドベースのセグメントは、2024年に48.85%の最大の収益シェアを占めました。このセグメントは、ハイドロゲル、ポリマースカフォールド、マイクロパターン表面加工マイクロプレート、ナノファイバーベースのスキャフォールドに分けられます。
• 幹細胞研究・組織工学セグメントは、2024年に34.23%のシェアで市場を独占しました。市場は、がん研究、幹細胞研究・組織工学、医薬品開発・毒性試験、その他に区分されます。
• 最終用途分野では、バイオ医薬品・製薬企業分野が2024年に46.93%のシェアで市場を独占しました。市場は、バイオテクノロジー・製薬会社、学術研究機関、病院、その他に区分されます。
• 北米の3D細胞培養市場は世界市場を独占し、2024年には39.09%のシェアを占めました。同市場は、先進的な (2018～2030年)インフラの存在、新興国、主要企業の存在、各社が実施する様々な戦略的イニシアティブによって総体的に牽引されています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 業界分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 事業分析：技術別

• 3D細胞培養市場：技術別の変動分析
• スキャフォールドベース
  • スキャフォールドベースの市場規模、推定値・予測値 (2018～2030年)
  • ハイドロゲル
  • ポリマースキャフォールド
  • マイクロパターン表面マイクロプレート
  • ナノファイバーベースのスキャフォールド
• スキャフォールドフリー
  • スキャフォールドフリー市場規模、推定値・予測値 (2018～2030年)
  • ハンギングドロップマイクロプレート
  • ULAコーティングを施したスフェロイドマイクロプレート
  • 磁気浮上
• バイオリアクター
  • バイオリアクターの市場規模、推定値・予測値 (2018～2030年)
• マイクロ流体
  • マイクロ流体の市場規模、推定値・予測値 (2018～2030年)
• バイオプリンティング
  • バイオプリンティングの市場規模、推定値・予測値 (2018～2030年)

第5章 事業分析：用途別

• 3D細胞培養市場：用途別の変動分析
• がん研究
  • がん研究の市場規模、推定値・予測値 (2018～2030年)
• 幹細胞研究・組織工学
  • 幹細胞研究・組織工学の市場規模、推定値・予測値 (2018～2030年)
• 医薬品開発・毒性試験
  • 医薬品開発・毒性試験の市場規模、推定値・予測値 (2018～2030年)
• その他
  • その他市の場規模、推定値・予測値 (2018～2030年)

第6章 最終用途ビジネス分析

• 3D細胞培養市場：最終用途別の変動分析
• バイオテクノロジー・製薬会社
  • バイオテクノロジー・製薬会社の市場規模、推定値・予測値 (2018～2030年)
• 学術研究機関
  • 学術研究機関の市場規模、推定値・予測値 (2018～2030年)
• 病院
  • 病院の市場規模、推定値・予測値 (2018～2030年)
• その他
  • その他の市場規模、推定値・予測値 (2018～2030年)

第7章 事業分析：地域別

• 3D細胞培養市場：地域別シェア (2024年・2030年)
• 北米
  • 北米の3D細胞培養市場 (2018～2030年)
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の3D細胞培養市場 (2018～2030年)
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋の3D細胞培養市場 (2018～2030年)
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの3D細胞培養市場 (2018～2030年)
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ 3D細胞培養市場 (2018～2030年)
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析 (2024年)
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific, Inc
  • Merck KGaA
  • PromoCell GmbH
  • Lonza
  • Corning Incorporated
  • Avantor, Inc.
  • Tecan Trading AG
  • REPROCELL Inc.
  • CN Bio Innovations Ltd.
  • Lena Biosciences

List of Tables

• Table 1 List of abbreviation
• Table 2 Global 3D cell culture market, by region, 2018 - 2030 (USD Million)
• Table 3 North America 3D cell culture market, by country, 2018 - 2030 (USD Million)
• Table 4 North America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 5 North America 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 6 North America 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 8 U.S. 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 9 U.S. 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 10 Canada 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 11 Canada 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 12 Canada 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 13 Mexico 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 14 Mexico 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 15 Mexico 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 16 Europe 3D cell culture market, by country, 2018 - 2030 (USD Million)
• Table 17 Europe 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 18 Europe 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 19 Europe 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 20 Germany 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 21 Germany 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 22 Germany 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 23 UK 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 24 UK 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 25 UK 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 26 France 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 27 France 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 28 France 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 29 Italy 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 30 Italy 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 31 Italy 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 32 Spain 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 33 Spain 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 34 Spain 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 35 Denmark 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 36 Denmark 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 37 Denmark 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 38 Sweden 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 39 Sweden 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 40 Sweden 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 41 Norway 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 42 Norway 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 43 Norway 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific 3D cell culture market, by country, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 48 China 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 49 China 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 50 China 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 51 Japan 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 52 Japan 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 53 Japan 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 54 India 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 55 India 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 56 India 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 57 South Korea 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 58 South Korea 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 59 South Korea 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 60 Australia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 61 Australia 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 62 Australia 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 63 Thailand 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 64 Thailand 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 65 Thailand 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 66 Latin America 3D cell culture market, by country, 2018 - 2030 (USD Million)
• Table 67 Latin America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 68 Latin America 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 69 Latin America 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 70 Brazil 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 71 Brazil 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 72 Brazil 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 73 Argentina 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 74 Argentina 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 75 Argentina 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 76 MEA 3D cell culture market, by country, 2018 - 2030 (USD Million)
• Table 77 MEA 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 78 MEA 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 79 MEA 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 80 South Africa 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 81 South Africa 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 82 South Africa 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 86 UAE 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 87 UAE 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 88 UAE 3D cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 89 Kuwait 3D cell culture market, by technology, 2018 - 2030 (USD Million)
• Table 90 Kuwait 3D cell culture market, by application, 2018 - 2030 (USD Million)
• Table 91 Kuwait 3D cell culture market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 3D cell culture market: market outlook
• Fig. 9 Parent market outlook
• Fig. 10 3D cell culture market driver impact
• Fig. 11 3D cell culture market restraint impact
• Fig. 12 3D cell culture market: technology outlook and key takeaways
• Fig. 13 3D cell culture market: technology movement analysis
• Fig. 14 Scaffold based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Scaffold free market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Hanging drop microplates market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 3D cell culture market: application outlook and key takeaways
• Fig. 27 3D cell culture market: application movement analysis
• Fig. 28 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 3D cell culture market: end use outlook and key takeaways
• Fig. 33 3D cell culture market: end use movement analysis
• Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 North America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Mexico 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Europe 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 UK 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Germany 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 France 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Italy 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Spain 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Denmark 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Sweden 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Norway 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Asia Pacific 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 China 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Japan 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 India 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Thailand 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 South Korea 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Australia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Latin America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Brazil 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)

3D Cell Culture Market Growth & Trends:

The global 3D cell culture market size is expected to reach USD 3.21 billion by 2030, registering a CAGR of 11.72% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in June 2023, Pixelgen Technologies launched its first molecular pixelation kit for 3D spatial study of proteins present on cell surface.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2023, AIM Biotech and MatTek partnered together to offer innovative idenTX and organiX microfluidic 3D tissue culture platforms along with complete drug discovery research services in specific areas of neurobiology, immune-oncology, and vascular biology.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds. Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

However, the lack of consistency in 3D cell model products is one of the major drawbacks that is expected to hinder the growth of the market. Moreover, various factors such as variability in cell culture, standardized challenges, scale & manufacturing issues, and quality control issues might hamper the market growth.

3D Cell Culture Market Report Highlights:

• The scaffold-based segment held the largest revenue share of 48.85% in 2024. The segment is divided into hydrogels, polymeric scaffolds, micropatterned surfaced microplates, and nanofiber-based scaffolds.
• The stem cell research & tissue engineering segment dominated the market with a share of 34.23% in 2024. The market is segmented into cancer research, stem cell research & tissue engineering, drug development & toxicity testing, and others.
• In the end-use segment, the biopharmaceutical & pharmaceutical companies segment dominated the market with a share of 46.93% in 2024. The market is segmented into biotechnology & pharmaceutical companies, academic & research institutes, hospitals, and others.
• North America 3D cell culture market dominated the global market and accounted for 39.09% share in 2024. The market is collectively driven by the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Technology Segment
  • 1.1.2. Application Segment
  • 1.1.3. End Use Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information or Data Analysis:
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Validation
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing demand for organ transplantation & tissue engineering
    • 3.2.1.2. Technological advancements in scaffold free technology
    • 3.2.1.3. Rise in investments and R&D funding for cell-based research
    • 3.2.1.4. Increasing focus on developing alternative to animal testing
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost associated with implementation
    • 3.2.2.2. Lack of compatibility and consistency
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

• 4.1. 3D Cell Culture Market: Technology Movement Analysis
• 4.2. Scaffold Based
  • 4.2.1. Scaffold based market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.2.2. Hydrogels
    • 4.2.2.1. Hydrogels market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.2.3. Polymeric Scaffolds
    • 4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.2.4. Micropatterned Surface Microplates
    • 4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.2.5. Nanofiber Based Scaffolds
    • 4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.3. Scaffold Free
  • 4.3.1. Scaffold free market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Hanging Drop Microplates
    • 4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Spheroid Microplates with ULA coating
    • 4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3.4. Magnetic Levitation
    • 4.3.4.1. Magnetic levitation market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.4. Bioreactors
  • 4.4.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Microfluidics
  • 4.5.1. Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Bioprinting
  • 4.6.1. Bioprinting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. 3D Cell Culture Market: Application Movement Analysis
• 5.2. Cancer Research
  • 5.2.1. Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.3. Stem Cell Research & Tissue Engineering
  • 5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.4. Drug Development & Toxicity Testing
  • 5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Others
  • 5.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. 3D Cell Culture Market: End Use Movement Analysis
• 6.2. Biotechnology & Pharmaceutical Companies
  • 6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.3. Academic & Research Institutes
  • 6.3.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. 3D Cell Culture Share By Region, 2024 & 2030
• 7.2. North America
  • 7.2.1. North America 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Target Disease Prevalence
    • 7.2.2.4. U.S. 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Target Disease Prevalence
    • 7.2.3.4. Canada 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Competitive Scenario
    • 7.2.4.3. Target Disease Prevalence
    • 7.2.4.4. Mexico 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.4.5.
• 7.3. Europe
  • 7.3.1. Europe 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Target Disease Prevalence
    • 7.3.2.4. UK 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Target Disease Prevalence
    • 7.3.3.4. Germany 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Target Disease Prevalence
    • 7.3.4.4. France 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Target Disease Prevalence
    • 7.3.5.4. Italy 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Target Disease Prevalence
    • 7.3.6.4. Spain 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Competitive Scenario
    • 7.3.7.3. Target Disease Prevalence
    • 7.3.7.4. Denmark 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Target Disease Prevalence
    • 7.3.8.4. Sweden 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Target Disease Prevalence
    • 7.3.9.4. Norway 3D Cell Culture, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Target Disease Prevalence
    • 7.4.2.4. Japan 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Target Disease Prevalence
    • 7.4.3.4. China 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Target Disease Prevalence
    • 7.4.4.4. India 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4.5. Australia
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Target Disease Prevalence
    • 7.4.5.4. Australia 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Target Disease Prevalence
    • 7.4.6.4. Thailand 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4.7. South Korea
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Target Disease Prevalence
    • 7.4.7.4. South Korea 3D Cell Culture, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Target Disease Prevalence
    • 7.5.2.4. Brazil 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Target Disease Prevalence
    • 7.5.3.4. Argentina 3D Cell Culture, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Target Disease Prevalence
    • 7.6.2.4. South Africa 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Target Disease Prevalence
    • 7.6.3.4. Saudi Arabia 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Target Disease Prevalence
    • 7.6.4.4. UAE 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Target Disease Prevalence
    • 7.6.5.4. Kuwait 3D Cell Culture, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Thermo Fisher Scientific, Inc
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Merck KGaA
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. PromoCell GmbH
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Lonza
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Corning Incorporated
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Avantor, Inc.
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Tecan Trading AG
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. REPROCELL Inc.
    • 8.4.8.1. Overview
    • 8.4.8.2. Product Benchmarking
    • 8.4.8.3. Strategic Initiatives
  • 8.4.9. CN Bio Innovations Ltd.
    • 8.4.9.1. Overview
    • 8.4.9.2. Product Benchmarking
    • 8.4.9.3. Strategic Initiatives
  • 8.4.10. Lena Biosciences
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives